Return to homepagePandemic Pact

EARLY DIAGNOSIS OF COVID-19 THROUGH THE ISOLATION OF EXOSOMES IN INDIVIDUALS SUSPICIOUS OF THE DISEASE.

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00155

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    MARÍA DEL PILAR, MARTÍN DUQUE

  • Research Location

    Spain

  • Lead Research Institution

    INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

SARS-CoV-2 or Covid-19 is a new type of coronavirus that causes a serious respiratory infection. Following the WHO indications, it has been announced that new diagnostic tests will be used shortly, much faster, but also more imprecise that may give false positives and negatives. In addition, during the first moments of the infection, some patients were initially negative, despite being infected, with the subsequent transmission of the infection. Given that genetic material of coronavirus has been found in serum exosomes and HIV-1 in urine exosomes of infected people, here we suggest carrying out diagnostic tests on the exosomes of urine, plasma and saliva of patients at different times of the study, in order to detect it more reliably and earlier.